Drug-Eluting Cardiac Stent

About Drug-Eluting Cardiac Stent

The Drug-Eluting Cardiac Stent (DES) is used during coronary angioplasty to treat narrowed or blocked coronary arteries caused by coronary artery disease. Once deployed inside the artery through a catheter-based delivery system, the stent expands to support the vessel wall and maintain arterial patency. The stent is coated with a therapeutic drug that is gradually released to reduce tissue growth within the artery, helping minimize the risk of re-narrowing and improving long-term clinical outcomes.

• Drug-eluting technology to reduce restenosis risk
• High radial strength for durable vessel scaffolding
• Flexible stent design for smooth deliverability
• Controlled expansion for precise stent placement
• Compatible with standard PTCA delivery systems
• Sterile, single-use interventional implant

Certifications

We are certified with CE, ISO 13485, and ISO 9001 standards.

Product Keywords

Drug Eluting Cardiac Stent, DES Stent, Coronary Drug-Eluting Stent, PCI Stent, Anti-Restenosis Stent, Interventional Cardiology Stent

دعامة قلبية مطلية بالأدوية، دعامة DES، دعامة الشريان التاجي المطلية بالأدوية، دعامة PCI، دعامة مضادة لتضيق الشريان، دعامة طب القلب التداخلي

Стенты с лекарственным покрытием для сердца, стенты с лекарственным покрытием, коронарные стенты с лекарственным покрытием, стенты для ЧКВ, антирестенотические стенты, интервенционные кардиологические стенты

Stent cardíaco liberador de fármacos, stent DES, stent coronario liberador de fármacos, stent PCI, stent antirreestenosis, stent de cardiología intervencionista

Stent cardiaque à élution de médicament, stent DES, stent coronaire à élution de médicament, stent PCI, stent anti-resténose, stent de cardiologie interventionnelle